Exploring clinical indicator variations in stroke patients with multiple risk factors: focus on hypertension and inflammatory reactions

被引:0
作者
Guo, Jiejie [1 ,2 ,3 ]
Tian, Mei [4 ,5 ]
Li, Yongang [3 ]
Guo, Yitong [5 ]
Zhang, Ting [2 ]
Liu, Xuan [3 ]
Shen, Jinze [5 ]
Zhang, Lin [3 ]
Yu, Yueqi [5 ]
Cao, Ling [6 ]
Gu, Haiyan [6 ]
Li, Yanfang [6 ]
Duan, Shiwei [5 ]
Wang, Qinwen [1 ]
机构
[1] Ningbo Univ, NBU Hlth Sci Ctr, Zhejiang Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Affiliated Wenling Hosp, Dept Clin Lab, Wenling 317500, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Wenling Hosp, Dept Neurol, Wenling 317500, Zhejiang, Peoples R China
[4] Zhejiang Univ Technol, Coll Pharm, Hangzhou 310014, Zhejiang, Peoples R China
[5] Hangzhou City Univ, Sch Med, Key Lab Novel Targets & Drug Study Neural Repair Z, Hangzhou 310015, Zhejiang, Peoples R China
[6] Ningbo Rehabil Hosp, Ningbo 315040, Peoples R China
关键词
Stroke; Risk factors; Ischemic stroke subtype; Clinical indicators; Inflammatory reactions; HEALTH-CARE PROFESSIONALS; ATRIAL-FIBRILLATION; ISCHEMIC-STROKE; T-CELLS; CYTOKINE EXPRESSION; ARTERY-DISEASE; HOMOCYSTEINE; MANAGEMENT; HYPERGLYCEMIA; ASSOCIATION;
D O I
10.1186/s40001-024-01653-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Stroke stands as the second leading cause of death worldwide. Currently, extensive research has been conducted on stroke risk factors. However, when stroke patients contend with multiple risk factors, the impact on clinical indicators remains uncertain. Objectives This study seeks to investigate potential significant variations among distinct ranges of clinical indicators in instances where stroke patients experience multiple risk factors and various ischemic stroke subtypes. Material and methods The research encompassed 440 stroke patients admitted to the First People's Hospital of Wenling City, Zhejiang Province, China. These patients were classified based on the type and quantity of risk factors and subtypes of ischemic stroke they presented. The chi 2 test was employed to assess the relationship between the risk of comorbid diseases and clinical indicators in stroke patients. Results The results of our study have underscored a significant correlation between various comorbid risk factors in stroke patients and the patients' age (P < 0.010). Furthermore, we observed noteworthy disparities in the plasma levels of IL-2, IL-4, IL-6, IL-10, TNF-alpha, and INF-gamma between patients devoid of risk factors and those presenting with comorbid risk factors associated with stroke. Significant differences in INF-gamma were observed between the two subtypes of ischemic stroke, namely lacunar infarction and cardioembolic stroke. Conclusion Age is correlated with an elevated risk of stroke. Individuals exhibiting multiple stroke risk factors and diverse ischemic stroke subtypes commonly present with abnormal lipid levels and imbalances in Th1/Th2 cytokines. These factors significantly contribute to the onset and progression of stroke. Furthermore, inflammatory responses, particularly those induced by atherosclerosis, play a pivotal role in the genesis of stroke and exert a substantial influence on its prognosis.
引用
收藏
页数:19
相关论文
共 56 条
  • [1] Mortality in atrial fibrillation. Is it changing?
    Alonso, Alvaro
    Almuwaqqat, Zakaria
    Chamberlain, Alanna
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2021, 31 (08) : 469 - 473
  • [2] Classification of Stroke Subtypes
    Amarenco, P.
    Bogousslavsky, J.
    Caplan, L. R.
    Donnan, G. A.
    Hennerici, M. G.
    [J]. CEREBROVASCULAR DISEASES, 2009, 27 (05) : 493 - 501
  • [3] The Role of Biomarkers in Atherothrombotic Stroke-A Systematic Review
    Andone, Sebastian
    Bajko, Zoltan
    Motataianu, Anca
    Mosora, Oana
    Balasa, Rodica
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [4] [Anonymous], 2012, Duke Med Health News, V18, P1
  • [6] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
    Baigent, C.
    Blackwell, L.
    Emberson, J.
    Holland, L. E.
    Reith, C.
    Bhala, N.
    Peto, R.
    Barnes, E. H.
    Keech, A.
    Simes, J.
    Collins, R.
    [J]. LANCET, 2010, 376 (9753) : 1670 - 1681
  • [7] Clinical Predictors of Risk for Atrial Fibrillation: Implications for Diagnosis and Monitoring
    Brunner, Kyle J.
    Bunch, T. Jared
    Mullin, Christopher M.
    May, Heidi T.
    Bair, Tami L.
    Elliot, David W.
    Anderson, Jeffrey L.
    Mahapatra, Srijoy
    [J]. MAYO CLINIC PROCEEDINGS, 2014, 89 (11) : 1498 - 1505
  • [8] Ischaemic stroke
    Campbell, Bruce C., V
    De Silva, Deidre A.
    Macleod, Malcolm R.
    Coutts, Shelagh B.
    Schwamm, Lee H.
    Davis, Stephen M.
    Donnan, Geoffrey A.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
  • [9] Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients - A systematic overview
    Capes, SE
    Hunt, D
    Malmberg, K
    Pathak, P
    Gerstein, HC
    [J]. STROKE, 2001, 32 (10) : 2426 - 2432
  • [10] Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays
    Chayoua, W.
    Kelchtermans, H.
    Moore, G. W.
    Musial, J.
    Wahl, D.
    de Laat, B.
    Devreese, K. M. J.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (10) : 2016 - 2023